Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 875670, 4 pages
http://dx.doi.org/10.1155/2014/875670
Clinical Study

Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy

Urology Department, Centro Medico Nacional “20 de Noviembre” México, Félix Cuevas 540, Del Valle, Benito Juárez, 03100 Ciudad de México, DF, Mexico

Received 23 April 2014; Accepted 23 June 2014; Published 3 September 2014

Academic Editor: Gabriel Sandblom

Copyright © 2014 Edgar Linden-Castro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Aus, C. C. Abbou, M. Bolla et al., “EAU guidelines on prostate cancer,” European Urology, vol. 48, no. 4, pp. 546–551, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Raaijmakers, W. J. Kirkels, M. J. Roobol, M. F. Wildhagen, and F. H. Schrder, “Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program,” Urology, vol. 60, no. 5, pp. 826–830, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. V. Rodríguez, “Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature,” Journal of Urology, vol. 160, no. 6, pp. 2115–2120, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. P. R. Sieber, F. M. Rommel, C. G. Theodoran, R. D. Hong, and M. A. Del Terzo, “Contemporary prostate biopsy complication rates in community-based urology practice,” Urology, vol. 70, no. 3, pp. 498–500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. A. Lindert, J. N. Kabalin, and M. K. Terris, “Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy,” Journal of Urology, vol. 164, no. 1, pp. 76–80, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Thompson, R. W. Talbot, D. A. Packham, and C. Dulake, “Transrectal biopsy of the prostate and bacteraemia,” British Journal of Surgery, vol. 67, no. 2, pp. 127–128, 1980. View at Publisher · View at Google Scholar · View at Scopus
  7. E. D. Crawford, A. L. Haynes Jr., M. W. Story, and T. A. Borden, “Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy,” Journal of Urology, vol. 127, no. 3, pp. 449–451, 1982. View at Google Scholar · View at Scopus
  8. D. A. Kapoor, I. W. Klimberg, G. H. Malek et al., “Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy,” Urology, vol. 52, no. 4, pp. 552–558, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Carey and H. J. Korman, “Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?” Journal of Urology, vol. 166, no. 1, pp. 82–85, 2001. View at Publisher · View at Google Scholar
  10. N. R. Webb and H. H. Woo, “Antibiotic prophylaxis for prostate biopsy,” BJU International, vol. 89, no. 8, pp. 824–828, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. H. M. Taylor and J. B. Bingham, “The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy,” Brain and Language, vol. 52, no. 10, pp. 787–790, 1997. View at Google Scholar · View at Scopus
  12. WHO Expert Consultation, “Appropriate body-mass index for populations and its implications for policy and intervention strategies,” The Lancet, vol. 363, no. 9403, pp. 157–163, 2004. View at Google Scholar
  13. F. M. E. Wagenlehner, E. van Oostrum, P. Tenke et al., “Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study,” European Urology, vol. 63, no. 3, pp. 521–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Adibi, B. Hornberger, D. Bhat, G. Raj, C. G. Roehrborn, and Y. Lotan, “Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis,” Journal of Urology, vol. 189, no. 2, pp. 535–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Loeb, A. Vellekoop, H. U. Ahmed et al., “Systematic review of complications of prostate biopsy,” European Urology, vol. 64, no. 6, pp. 876–892, 2013. View at Publisher · View at Google Scholar
  16. B. C. Griffith, A. F. Morey, M. M. Ali-Khan, E. Canby-Hagino, J. P. Foley, and T. A. Rozanski, “Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk,” Journal of Urology, vol. 168, no. 3, pp. 1021–1023, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Feliciano, E. Teper, M. Ferrandino et al., “The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis?” Journal of Urology, vol. 179, no. 3, pp. 952–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. K. Taylor, T. R. Zembower, R. B. Nadler et al., “Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care,” Journal of Urology, vol. 187, no. 4, pp. 1275–1279, 2012. View at Publisher · View at Google Scholar · View at Scopus